After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NYSE listed company, HIMS falls under the Healthcare sector while operating within the Drug Manufacturers – Specialty & Generic industry segment. The current market capitalization of Hims & Hers Health Inc is $7.76B. A total of 9.14 million shares were traded on the day, compared to an average of 23.21M shares.
In the most recent transaction, Okupe Oluyemi sold 23,090 shares of HIMS for 35.72 per share on Dec 22 ’25. After the transaction, the Chief Financial Officer now owns 94,333 company shares. In a previous transaction on Dec 22 ’25, Oluyemi Okupe bought 32,160 shares at 35.05 per share.
Among the insiders who sold shares, Chi Michael disposed of 13,750 shares on Dec 17 ’25 at a per-share price of $36.71. This resulted in the Chief Operating Officer holding 305,161 shares of HIMS after the transaction. In another insider transaction, Autor Deborah M. sold 7,054 shares at $36.71 per share on Dec 17 ’25. Company shares held by the Chief Policy Officer now total 6,175.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, HIMS has a high of $72.98 and a low of $23.97.
As of this writing, HIMS has an earnings estimate of $0.05 per share for the current quarter. EPS was calculated based on a consensus of 11.0 estimates, with a high estimate of $0.15 per share and a lower estimate of -$0.04. The company reported an EPS of $0.11 in the last quarter
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. HIMS’s latest balance sheet shows that the firm has $247.27M in Cash & Short Term Investments as of fiscal 2021. There were $5.48M in debt and $79.22M in liabilities at the time. Its Book Value Per Share was $2.55, while its Total Shareholder’s Equity was $334.62M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for HIMS is Buy with a score of 3.36.
